Eliisa Löyttyniemi

- Doctoral Researcher,
Paediatrics and Adolescent Medicine (Department of Clinical Medicine)
- Biostatistic,
Biostatistics (Department of Clinical Medicine)

eliisa.loyttyniemi@utu.fi

+358 29 450 4450

+358 50 308 2458

Kiinamyllynkatu 10

Turku

Teaching and consulting biostatistics, and analysing all kind of datasets

Biostatistics especially in clinical trials

16 of 17

Electric field navigated transcranial magnetic stimulation for chronic tinnitus: A pilot study (2015)
- International Journal of Audiology
Sahlsten H, Isohanni J, Haapaniemi J, Salonen J, Paavola J, Loyttyniemi E, Johansson R, Jaaskelainen SK
Expression of cohesin subunit SA2 predicts breast cancer survival (2015)
- Annals of Oncology
Repo H, Loyttyniemi E, Nykanen M, Lintunen MM, Karra H, Soderstrom M, Kuopio T, Kronqvist P
Mobile phone text message reminders: Measuring preferences of people with antipsychotic medication (2015)
- Schizophrenia Research
Kauppi K, Kannisto KA, Hätönen H, Anttila M, Löyttyniemi E, Adams CE, Välimäki M.
Muscle-specific glucose and free fatty acid uptake after sprint interval and moderate-intensity training in healthy middle-aged men (2015)
- Journal of Applied Physiology
Eskelinen JJ, Heinonen I, Loyttyniemi E, Saunavaara V, Kirjavainen A, Virtanen KA, Hannukainen JC, Kalliokoski KK
Neonatal Antibiotic Exposure Alters Compositional Gut Microbiota Development During the First 6 Months of Life (2015)
- FASEB Journal
Kumar H, Rautava S, Collado M, Borzykh N, Loyttyniemi E, Isolauri E, Salminen S
A PET Tracer for Brain α2C Adrenoceptors, 11C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice (2014)
- Journal of Nuclear Medicine
Arponen E, Helin S, Marjamäki P, Grönroos T, Holm P, Löyttyniemi E, Någren K, Scheinin M, Haaparanta-Solin M, Sallinen J, Solin O
Cdc20 and securin overexpression predict short-term breast cancer survival (2014)
- British Journal of Cancer
Karra H, Repo H, Ahonen I, Löyttyniemi E, Pitkänen R, Lintunen M, Kuopio T, Söderström M, Kronqvist P
Evaluation of repeated [18F]EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas (2014)
- EJNMMI Research
Silvoniemi Antti, Silén Jonna, Forsback Sarita, Löyttyniemi Eliisa, Schrey Aleksi R, Solin Olof, Grénman Reidar, Minn Heikki, Grönroos Tove J
Moderate Intensity Training Has More Desirable Effects on Liver Metabolism than High-Intensity Interval Training in Healthy, Sedentary, and Middle-aged Men (2014)
- Diabetes
Motiani KK, Savolainen AA, Eskelinen JJ, Virtanen KA, Kapanen J, Parkkola R, Saunavaara V, Loyttyniemi E, Knuuti J, Nuutila P, Kalliokoski KK, Hannukainen JC
Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project (2014)
- European Psychiatry
Salokangas RKR, Heinimaa M, From T, Löyttyniemi E, Ilonen T, Luutonen S, Hietala J, Svirskis T, von Reventlow HG, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Schultze-Lutter F, Ruhrman S, Klosterkötter J; the EPOS group
Trends of weekly musculoskeletal pain from 2000 to 2012: National study of Finnish university students. (2014)
- European Journal of Pain
Oksanen AM, Laimi K, Löyttyniemi E, Kunttu K.
Uptake of [18F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma (2014)
- Translational Oncology
Silén J, Högel H, Kivinen K, Silvoniemi A, Forsback S, Löyttyniemi E, Solin O, Grénman R, Minn H, Jaakkola PM, Grönroos TJ
Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women (2013)
- Osteoporosis International
T Pekkarinen, E Löyttyniemi, M Välimäki
Intermittent megadose treatment with vitamin D3 is not optimal to keep serum 25OHD levels at or over the target of 75 nmol/L (2013)
- Osteoporosis International
Valimaki VV, Pekkarinen T, Loyttyniemi E, Valimaki M
The effectiveness of teriparatide in the clinical practice-attenuation of the bone mineral density outcome by increasing age and bisphosphonate pretreatment (2013)
- Annals of Medicine
Koski AM, Loyttyniemi E, Vaananen H, Laine H, Niskanen L, Nevalainen PI, Korpi-Hyovalti E, Valimaki MJ
BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients (2012)
- APMIS
Pelttari H, Schalin-Jantti C, Arola J, Loyttyniemi E, Knuutila S, Valimaki MJ
Prevention of hip fractures with an educational program in elderly finnish women: a population-based randomized clinical trial (2012)
- Osteoporosis International
Pekkarinen TA, Loyttyniemi E, Valimaki MJ
First Trimester Folate Metabolism and Congenital Heart Defect (2011)
- Reproductive Sciences
Bahado-Singh RO, Akolekar R, Loyttyniemi E, Nicolaides KH
LONG-TERM EFFICACY AND TOLERABILITY OF ONCE-YEARLY HISTRELIN ACETATE IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER (2010)
- European Urology Supplements
Shore ND, Gittelman M, Cookson MS, Harnett MD, Loyttyniemi E, Vuorela A, Schlegel PN
Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study (2010)
- European Journal of Endocrinology
Pelttari H, Valimaki MJ, Loyttyniemi E, Schalin-Jantti C